Page last updated: 2024-10-26

dimaprit and Acute Myelogenous Leukemia

dimaprit has been researched along with Acute Myelogenous Leukemia in 2 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sawutz, DG2
Kalinyak, K1
Whitsett, JA2
Johnson, CL2
Kalinyak, KA1
Lampkin, BC1

Other Studies

2 other studies available for dimaprit and Acute Myelogenous Leukemia

ArticleYear
Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 231, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Cell Differentiation; Cell Line; Cimetidine; Cyclic AMP; Dimaprit; Dino

1984
Effects of dimaprit on growth and differentiation of human promyelocytic cell line, HL-60.
    Life sciences, 1985, May-20, Volume: 36, Issue:20

    Topics: Bone Marrow; Bone Marrow Cells; Bucladesine; Cell Differentiation; Cell Division; Cell Line; Cyclic

1985